Unrelated Double Umbilical Cord Blood Units Transplantation
The purpose of this study is to determine the safety and feasibility of unrelated double umbilical cord blood units Transplantation in patients with haematological malignancies using Antithymocyte Globulin Cyclophosphamide, busulfan as conditioning and cyclosporin, methylprednisolone as GVHD prophylaxis.
Leukemia, Myeloid, Acute|Leukemia, Lymphoblastic, Acute|Leukemia, Myeloid, Chronic
DRUG: Stem cell Transplantation
To determine the Benefit and Side Effects of Double Umbilical Cord Blood Units Stem Cell Transplantation in Hematologic Malignancies, Until end of study
Neutrophil and platelet engraftment, 1 year|Severity of acute graft-vs-host disease(GvHD, 1 year|Early transplant related mortality, 100 days|Overall and disease free survival at one years, 1 year
The purpose of this study is to determine the safety and feasibility of unrelated double umbilical cord blood units Transplantation in patients with haematological malignancies using Antithymocyte Globulin Cyclophosphamide, busulfan as conditioning and cyclosporin, methylprednisolone as GVHD prophylaxis.